Bills: HF4609, HF4401

Keywords: infertility, fertility treatment, fertility preservation, IVF, assisted reproductive technology, ART, oocyte retrieval, embryo transfer, egg freezing, sperm freezing, reproductive health, maternity coverage, health insurance mandate, health plan benefits, Medical Assistance, Medicaid, MinnesotaCare, family planning, oncology fertility preservation, chemotherapy

Transcript Highlights:

• One of those is a chemotherapy infusion clinic in our hospital.
• One of those is a chemotherapy infusion clinic in our hospital.
• One of those is a chemotherapy infusion clinic in our hospital.
• One of those is a chemotherapy infusion clinic in our hospital.
• <00:20:26.240> that's<00:20:26.400> a a round of chemotherapy that's a a round of chemotherapy

Keywords: 00:00 Introductions 02:46 Roll Call 03:35 Discussion on SB 14 46:13 Vote on SB 14 48:07 Discussion on SB 17 50:38 Vote on SB 17, 958, all

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• On April 24, Larry's chemotherapy began.
• On April 24, Larry's chemotherapy began.
• In January 20th, in Boston, I started my care on chemotherapy.
• The chemotherapy that I started on has been the same chemotherapy drug The chemotherapy that I started
• on has been the same chemotherapy drug for the last 50 years.

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• The command center is staffed by senior chemotherapy-trained nurses, advanced practice providers, and
• senior chemotherapy nurse is on the line to troubleshoot, to help with any questions.
• So one senior chemotherapy nurse can actually oversee a number of home health nurses.
• So one senior chemotherapy nurse can actually oversee a number of home health nurses.
• If it's a subcutaneous injection, it doesn't need a chemotherapy-trained nurse.

Summary: The Health Care Budget Subcommittee held a panel discussion on Florida’s cancer research and funding programs, including the Casey DeSantis Cancer Research Program, the Florida Cancer Innovation Fund, the James and Esther King Biomedical Research Program, the Bankhead-Coley Research Program, and Live Like Bella. Dr. Ladapo and leaders from Moffitt, Sylvester/University of Miami, UF Health, and Mayo Clinic described how state funding has helped Florida’s four NCI-designated cancer centers expand research, recruit faculty, increase clinical trials, and build collaborations. They emphasized that the programs are intended to improve cancer care statewide, support innovation, and encourage more institutions to pursue NCI designation. The Governor’s budget recommendation was noted as including additional funding, and members asked about the cost and requirements of becoming NCI-designated and eventually comprehensive. Panelists said NCI designation requires major infrastructure, compliance, research, and training investments, with de novo development estimated at about $1 billion. They described Florida’s collaborative model as unusual nationally, with annual symposia, shared pilot funding, and joint projects across the four centers. Members also asked about rural access, home-based care, and recruitment/retention. Mayo described its “Cancer Care Beyond Walls” home-treatment model and said it could expand to rural counties within months; Moffitt and UF discussed mobile screening, satellite sites, and affiliations with local hospitals and practices. Several members raised concerns about workforce shortages, licensure delays, and the need to reach underserved areas. The discussion also covered outcomes, data reporting, and the broader economic impact of the cancer centers. Panelists cited growth in jobs, federal research funding, and clinical trial enrollment, and highlighted advances in immunotherapy, CAR-T, TIL therapy, carbon ion therapy, AI-driven screening, and the firefighter cancer initiative. They said the Florida Cancer Data System is being expanded to track recurrence and quality-of-life measures. Members also asked about philanthropy, medical tourism, and federal funding risks, including possible indirect cost reductions that could affect research budgets. The meeting ended with general support for continued investment, while some members noted an ongoing policy debate over whether future cancer research dollars should be concentrated in the four NCI centers or spread more broadly across the state.

Transcript Highlights:

• So we have not updated the oral cancer coverage for oral chemotherapy medicines since 2012.
• this was brought to us by several doctors who are finding that now that we have more oral cancer chemotherapy
• So we have not updated the oral cancer coverage for oral chemotherapy medicines since 2012.
• this was brought to us by several doctors who are finding that now that we have more oral cancer chemotherapy
• And so we're trying to... ...cancer chemotherapy drugs.

Bills: HB591, HB766

Keywords: family leave, insurance, paid leave, employment benefits, caregiver support, cancer treatment, anti-cancer medications, health insurance, copayment, cost-sharing, health policy, 974, senate, all

Transcript Highlights:

• So we have not updated the oral cancer coverage for oral chemotherapy medicines since 2012.
• this was brought to us by several doctors who are finding that now that we have more oral cancer chemotherapy
• So we have not updated the oral cancer coverage for oral chemotherapy medicines since 2012.
• this was brought to us by several doctors who are finding that now that we have more oral cancer chemotherapy
• And so we're trying to... ...cancer chemotherapy drugs.

Summary: The Senate Insurance Committee met on May 20, confirmed a quorum, and approved the May 13 minutes. The first bill heard was House Bill 591, which would create the Paid Family Leave Insurance Act as a voluntary private-market insurance option for employers, with no mandate, state program, or taxpayer cost. Senator Bass presented the bill, offered technical amendments, and after brief questions about why the framework was needed, the committee adopted the amendments and reported the bill favorably with amendments. The committee then took up House Bill 76, dealing with coverage for orally administered anti-cancer medications. Representative Amy Freeman and former Representative Julie Stokes explained that the bill updates Louisiana’s oral chemotherapy coverage law, which had not been revised since 2012, and addresses insurer rejection of newer oral cancer drugs. They also explained Amendment Set 4063, which was intended to restore the bill to the proper posture after changes made in the Appropriations Committee and to prohibit copayment adjustment programs such as accumulator or maximizer programs from reducing credit for manufacturer assistance toward deductibles and out-of-pocket maximums. Senator Bass raised a concern about prior authorization language and possible ERISA litigation, and department staff responded that the bill would not alter ERISA enforceability and that the fiscal note already reflected about $67,000 in OGB costs. After the amendments were adopted, Senator Bass moved to report HB 76 favorably with amendments, and the committee did so without opposition. Senator Carter thanked the bill authors for their advocacy on cancer-related issues and offered to help during the interim. The committee then adjourned.

Transcript Highlights:

• Patients often don't know if scalp cooling will be covered before starting chemotherapy.
• This leads Patients often don't know if scalp cooling will be covered before starting chemotherapy.
• That is less than 2% of total chemotherapy costs and far less than even one single infusion.
• Driven by my passion for advocating for patients facing the side effects of chemotherapy, I now work
• We know that three out of four patients identify hair loss as the most feared side effect of chemotherapy

Keywords: 995, all

Summary: The committee heard testimony on a wide range of health insurance and public health bills, with most speakers focused on expanding coverage for specific treatments and services. Bills discussed included H. 1187/S. 792 on rehabilitation counselors, H. 1173/S. 692 on patient navigation, S. 2600 on scalp cooling for chemotherapy patients, S. 2599 on medically necessary treatment for port wine birthmarks, H. 1164 on licensed educational psychologists for child and adolescent mental health services, S. 754/H. 1254 on autism diagnosis and treatment by nurse practitioners and psychiatric nurse mental health clinical specialists, S. 714/H. 1137 on infectious disease response and coverage, and S. 791 on making nature a prescriptive therapeutic intervention. Speakers generally argued these bills would improve access, reduce out-of-pocket costs, and address gaps in current insurance reimbursement rules. Testimony in support emphasized personal stories and clinical evidence. Cancer patients and providers described the benefits of patient navigation and scalp cooling for dignity and quality of life during treatment. Boston Children’s Hospital staff and families said port wine birthmark treatment is medically necessary, can prevent complications, and should not be denied as cosmetic. Rehabilitation counselors and school psychologists argued their services are effective, cost-saving, and underused because they cannot bill insurance. Autism advocates said current insurance statutes are outdated because nurse practitioners and psychiatric nurse mental health clinical specialists already provide evaluations and should be recognized for reimbursement to avoid delays in early intervention. Public health and GLAD Law testimony supported stronger infectious disease coverage to remove barriers to testing, treatment, and PrEP access. The hearing also included extensive testimony on H. 1172, a bill requiring insurance coverage for detransition-related care. Supporters said it would ensure coverage for medically necessary care for people who regret or reverse gender transition, while opponents argued it would legitimize anti-trans narratives or, conversely, that detransition care is needed because transition procedures can cause harm. The committee also heard strong support for S. 791 from advocates who described nature access as a health intervention that could help with trauma, anxiety, substance use recovery, and environmental justice, with claims that insurance coverage and reduced park fees would improve access. No votes were taken during the transcript, and the chair repeatedly thanked speakers and moved through the long list of public testimony.

Transcript Highlights:

• Physicians were told to no longer do chemotherapy treatments; they were reserving those beds for COVID
• Physicians were told to no longer do chemotherapy treatments; they were reserving those beds for COVID
• Physicians were told to no longer do chemotherapy treatments; they were reserving those beds for COVID
• Physicians were told to no longer do chemotherapy treatments; they were reserving those beds for COVID
• treatments that they were chemotherapy treatments that they were reserving<00:08:37.800> those

Keywords: 958, all

Summary: The committee heard testimony on Senate Bill 132, a health care conscience-protection measure. Supporters said the bill would protect health care professionals from being forced to participate in procedures or services that violate sincerely held religious or ethical beliefs, while explicitly excluding emergency care. They argued it would help recruit and retain providers, preserve ethical integrity in medicine, and has worked in several other states. Supporters also emphasized that the bill is aimed at procedures or services, not at denying care based on who a patient is, and noted that the bill includes a civil cause of action to give it enforcement teeth. Several supporters described personal experiences. A nurse said lack of conscience protections affected her career choices and limited her path into women’s health. Dr. Warman said he had requested not to perform anesthesia for abortions and later chose non-narcotic pain management because he objected to heavy opioid prescribing, saying conscience protections allow professionals to practice responsibly. Senators asked about examples, the bill’s scope, whether it could be used to discriminate, and which states have similar laws; Mississippi, Florida, Montana, Ohio, South Carolina, and Arkansas were named. Questions also focused on the bill’s civil enforcement provisions and whether it could be used against patients based on identity or religion. Opponents warned the bill was overly broad and could allow refusals of care by a wide range of health workers, including clerks, ambulance drivers, pharmacists, nurses, and physicians. Dr. Karen Abrams said it could lead to denial of birth control, Plan B, blood transfusions, and other care, especially in rural areas with few alternatives, and could worsen Kentucky’s provider shortages. David Conway said the bill lacked patient protections, could increase delays and discrimination, and could prevent reassignment of objecting staff. The chair noted there were seven people signed up in opposition, limited testimony to two minutes each, and said the committee would return to the bill after hearing additional opposition and other pending bills.

Transcript Highlights:

• For many cancer patients, chemotherapy is vital, as it targets rapidly dividing cancer cells.
• Hair loss is one of the most visible and emotionally distressing side effects of chemotherapy.
• Although scalp cooling has been successful in reducing chemotherapy-induced hair loss, access remains
• Over 12 consecutive weeks of chemotherapy, I spent roughly 40 hours connected to the machine.
• It's a practical and compassionate step to support Californians undergoing chemotherapy.

Keywords: 987, senate, all

Transcript Highlights:

• It can make the difference in a cancer patient being able to avoid bulk treatments like chemotherapy
• able to avoid bulk<00:02:20.720> treatments<00:02:21.160> like<00:02:21.360> chemotherapy
• <00:02:22.040> and bulk treatments like chemotherapy and bulk treatments like chemotherapy

Keywords: Insurance - Room 210, 26 February, 2026; 9:00 A.M., 925, all

Summary: The committee considered several House bills, most of them already passed by the Senate or previously vetted in other committees. House Bill 1075 would expand access for low-income housing authorities and related entities to participate in insurance pooling arrangements, with the sponsor explaining it would help lower insurance costs as housing funding structures shift toward public-private partnerships. House Bill 565, renamed “Jill’s Law,” would advance biomarker testing and related Medicaid/prior authorization conforming changes; House Bill 856 would remove a repealer from the state’s anti-step-therapy law after hearings found the cost impact negligible; and House Bill 939 would extend the repealer on the volunteer firefighters’ Length of Service Award Program, which was described as needing ongoing funding to retain and recruit volunteers. The committee also heard House Bill 1019, which would expand health coverage options for small businesses, professionals, and self-employed people through access to regulated trade association self-funded group health plans. House Bill 1117 would create a transparency requirement for dental insurance by reporting premium-to-services information to the insurance commissioner and making it available in a portal; the sponsor said the Dental Association supports it. House Bill 1332 would require insurance examinations to meet National Association of Insurance Commissioners standards and best practices, and a member said he would vote present but the bill was said not to affect existing continuing education rules. Finally, House Bill 1713 would codify Mississippi Military Department authority to oversee state-sponsored life insurance for National Guard members, with the Adjutant General designated as state sponsor; it was described as voluntary, already operating since 1962, and without a fiscal note because it is paid for by guardsmen. Each bill received a motion to do pass or title sufficient to pass, was approved without opposition or with only a present vote noted on one bill, and the committee then voted to rise and report.

Transcript Highlights:

• House Bill 25, an act relating to coverage for scalp cooling systems used in connection with chemotherapy
• House Bill 25, an act relating to coverage for scalp cooling systems used in connection with chemotherapy
• cooling systems used in<00:30:09.360> connection<00:30:09.600> with<00:30:09.840> chemotherapy
• in connection with chemotherapy in connection with chemotherapy treatment<00:30:10.880> for

Keywords: Convene 00:00 Motions, Petitions, and Communications 04:28 Election and Swearing In of Constitutional Officers 04:35 Introduction of New Bills and Resolutions 06:51 HR 1 08:08 HR 2 08:40 HR 3 17:11 Impeachment Petitions reported 18:33 Introduction of New Bills and Resolutions 20:27 Stand at Ease 20:54 Introduction of New Bills and Resolutions 28:30 Adjournment 33:05, 958, all

Summary: The Kentucky House convened for the opening of the 2026 regular session, with prayer, the Pledge of Allegiance, roll call, and a declared quorum of 100 members present. The House then excused absent members and suspended the rules to allow co-sponsorships and vote modifications to be filed. It also elected House staff constitutional officers by acclamation, including the chief clerk, deputy clerk, sergeant at arms, chief doorkeeper, enrolling clerk, cloakroom keeper, and janitor, followed by the oath of office. Members introduced and adopted House Resolutions 1, 2, and 3. House Resolution 1 established the 2026 House membership. House Resolution 2 adopted the House rules for the session, with changes reflecting the new temporary building, removal of COVID-related provisions, elimination of remote and alternative voting, shortening motions/petitions/communications time from 30 to 15 minutes, deleting guest introductions and gallery references, requiring only one signed jacketed bill copy, clarifying billbook co-sponsorship procedures, deleting consent orders and pairing rules, and updating chamber-access and lobbying restrictions. Some members objected that the changes reduced transparency and public access, and one member asked that the 15-minute limit be kept at 30 minutes, but the resolution was adopted. House Resolution 3 invited pastors of Frankfurt churches to open sessions with prayer; one member asked that it be broadened to include people of all faiths and beyond Franklin County, but it was also adopted. The House then reported interim communications, including citizen impeachment petitions filed against Supreme Court Justice Pamela Goodwine and Ballard County Jailer Eric Cppus. Members were reminded of a mandatory ethics meeting the next day. The clerk reported the first batch of filed bills and resolutions, including House Bill 11 on independent school districts and House Bills 12 through 34 on topics such as legislative privacy, income tax, rural hospital funding, Medicaid and Medicaid expansion, school employee payments, firearms, reproductive health and privacy, employment schedules, cancer treatment coverage, workers’ compensation for first responders, savings accounts, education opportunity accounts, leave from employment, criminal procedure, home purchases, FNF devices, data privacy, and death benefits, along with House Resolutions 4 through 6. The House then adjourned until 2 p.m. on January 7, 2026.

Transcript Highlights:

• Bob says chemotherapy is a roller coaster ride in the pitch dark.
• me that she had received her diagnosis of cancer a year prior and that she had been receiving chemotherapy
• me that she had received her diagnosis of cancer a year prior and that she had been receiving chemotherapy

Summary: The Assembly convened after a quorum call, heard a prayer and pledge, and then handled routine procedural business, including dispensing with the journal reading, re-referring AB 2022, and rescinding prior action on SCR 112. Several bills on the second reading file and concurrence file were passed and retained, while reconsideration items were continued. The chamber then moved to third reading items and consent calendar business. The main substantive item was ACR 145, by Assemblymember Koloza, declaring March 1-7, 2026 as National Women in Construction Week. Koloza, Davies, Bauer-Kahan, and Arambula spoke in support, emphasizing the need to expand opportunities for women in the trades, improve apprenticeship pipelines, address barriers such as childcare, transportation, safety, and restroom access, and support women-owned construction businesses. The resolution was adopted by voice vote after 67 co-authors were added. On the second-day consent calendar, ACR 135 on School Breakfast Week was also taken up for co-authors, with 66 added, and the consent calendar passed 65-0, including ACR 135, ACR 144, and SCR 122. The Assembly also observed an adjournment in memory for Eileen Hubb, and the house adjourned until Monday, March 9 at 1 p.m.

Transcript Highlights:

• The treatment itself like chemotherapy, but it doesn't cover the auxiliary services for the aftereffects
• Cancer treatments such as chemotherapy, radiation therapy, and cancer surgery are powerful modalities
• patients with head and neck cancer may need to have damaged teeth extracted prior to receiving chemotherapy

Transcript Highlights:

• Cancer treatments such as chemotherapy and radiation can cause permanent infertility, leaving survivors
• It expands coverage to those facing infertility due to surgery, chemotherapy, radiation, or other medically
• Surgery, chemotherapy, radiation, or other medically necessary treatments; removes reproductive age restrictions

Summary: The Committee on Governmental Oversight and Accountability met and reported several bills favorably. Senate Bill 7000 repealed the sunset on a public records exemption protecting site-specific location information for threatened and endangered species; Senate Bill 7006 preserved exemptions for building plans and related records showing 911, E911, public safety radio, and NG911 infrastructure; and Senate Bill 7004 extended the exemption for property photographs and personal identifying information tied to certain housing assistance programs. Each of those bills drew no questions, no public testimony, and no debate before favorable votes. The committee also considered Senate Bill 448 on administrative procedure, which proposed broader reforms to the Administrative Procedure Act, including agency rulemaking oversight and cost-benefit analysis requirements. An amendment removed the bill’s eight-year sunset. The Florida Bar’s Administrative Law Section testified with concerns that some provisions could chill agency guidance, increase costs and delays, and create standing issues for challenges. Supportive testimony also came from Americans for Prosperity and the James Madison Institute. After debate, the committee reported the bill favorably as amended. Senate Bill 1058, as amended, updated state references to the “Gulf of America” in geographic and instructional materials and removed the road designation of Tamami Trail. Senator Polsky objected to the change as unnecessary and wasteful, while the sponsor said the bill simply aligns materials with the new name going forward. The committee adopted the strike-all amendment and then reported the bill favorably. Later, Senate Bill 924 was heard and amended to expand state employee fertility preservation coverage beyond cancer to other medically necessary treatments, remove age limits, require coverage of standard cryopreservation services, and set storage limits. Senators Polsky and Rodriguez praised the measure as important for young patients facing infertility risks, while one senator questioned whether the state group plan was the right vehicle. The committee reported SB 924 favorably, and members later recorded additional affirmative votes on SB 448 and SB 1058 before adjournment.

Transcript Highlights:

• Before any cancer treatment plan involving chemotherapy or radiation could proceed, all necessary and
• I also had some sessions of radiation and chemotherapy for some of these.
• I have been saying... chemotherapy for some of these.
• During chemotherapy, I had adverse reactions to all the usual palliative medications, the ones used for
• When I was released, I continued chemotherapy with no access to anti-nausea medications.

Keywords: 995, all

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.

Transcript Highlights:

• Immediately, I began 16 rounds of chemotherapy and 21 rounds of radiation.
• By my second chemotherapy treatment, my hair was falling out, and I shaved my head bald, surrounded by
• Not only does she have the decreased appetite and nausea related to her chemotherapy treatment, but she

Transcript Highlights:

• Immediately I began 16 rounds of chemotherapy and 21 rounds of radiation.
• By my second chemotherapy treatment, my hair was falling out in clumps.
• Um, not only does she have the decreased appetite and nausea related to her chemotherapy treatment, she

Transcript Highlights:

• I'm not allowed to suggest a chemotherapy that I know the outcomes are worse than the other options we
• I'm not allowed to suggest a chemotherapy<00:52:12.559> that<00:52:12.880> I<00:52:13.200
• chemotherapy that I know the outcomes are<00:52:15.280> worse<00:52:16.000> than<00:52
• It does have an interest in paying for chemotherapy because that is a physical disease that someone is
• is paying for chemotherapy because that is a<00:53:38.640> physical<00:53:39.119> disease<

Keywords: 958, all

Summary: The committee first took up administrative regulations, found no concerns, and then passed House Bill 389 with a favorable expression by a 9-0 vote. HB 389 was described as a cleanup bill for the CASPER prescription monitoring program: it clarifies that practitioners must have active CASPER accounts, exempts charitable health care providers from e-prescribing requirements, allows sharing CASPER data with certain federal entities such as military-base providers, and updates references to hydrocodone’s Schedule II status. The sponsor said there was no expected fiscal impact. The committee then passed House Bill 392, also by a 9-0 favorable expression. HB 392 would streamline payment for non-elective medical care for patients in state mental facilities when the facility cannot provide the needed treatment, allowing care in community-based settings and payment to those providers. The sponsor said the bill was intended to improve efficiency and would not have a fiscal impact on the cabinet. House Bill 501 was next and likewise passed 9-0 with favorable expression. The bill would allow pharmacists, in their professional judgment, to refill certain prescriptions for up to 180 days when a physician has died, while excluding controlled substances and preserving pharmacist discretion to require follow-up care. Senators raised concerns that the bill does not require patients to seek a new provider during that period, but supporters said the longer window addresses rural provider shortages and access delays. The committee then heard House Bill 495, as amended by a committee substitute. The substitute would prohibit Medicaid services and managed care organizations from covering cross-sex hormones above normal levels and gender reassignment surgery. Testimony on the bill was overwhelmingly opposed, with speakers including a former senator, psychologists, advocates, and legal and social work representatives arguing that conversion therapy is harmful, that the substitute would deny medically necessary gender-affirming care, and that the measure could increase suicide risk and litigation. One witness from the Family Foundation of Kentucky spoke in favor, arguing the executive order on counseling limits free speech and that counseling should not be restricted by government. The transcript ends during testimony, with no final committee vote on HB 495 shown.

Transcript Highlights:

• He was diagnosed with throat cancer at 69, and he endured radiation and chemotherapy.
• At 69, he endured radiation and chemotherapy.
• He underwent palliative chemotherapy and took heavy doses of oral narcotics.
• Ever since then, I've been on chemotherapy.
• This time she said, no, I don't want to go through chemotherapy.

Keywords: 995, all

Summary: The Joint Committee on Public Health opened its first hearing of the session and heard testimony on bills in three areas: emergency medical services/AED access, athletic training and student safety, and end-of-life options. Committee chairs outlined testimony rules and noted that written testimony would also be accepted. Some bills had no live witnesses, while others drew extensive testimony from advocates, professionals, and legislators. On AED-related bills, the American Heart Association supported requiring automated external defibrillators at sporting events and athletic fields, citing sudden cardiac arrest survival rates and urging cardiac emergency response plans as an added safeguard. A parks and recreation professional supported AED access but raised concerns about the cost, staffing, maintenance, and feasibility for municipalities with limited resources. Athletic trainers supported expanding their scope of practice and removing workplace restrictions, arguing it would improve injury prevention, reduce costs, and help retain professionals in Massachusetts. The committee also took extensive testimony on end-of-life options legislation. Supporters included legislators, physicians, hospice volunteers, clergy, patients’ family members, and advocacy groups, who described the bills as allowing terminally ill, mentally capable adults to choose a peaceful death with strict safeguards and self-administration requirements. They emphasized personal stories of suffering, public support, and the claim that other states have not seen abuse. Opponents, including faith-based, disability-rights, and family policy representatives, argued the bills amount to physician-assisted suicide, could pressure vulnerable people, and may be influenced by prognosis errors, coercion, or financial incentives. No votes or final committee actions were taken during the hearing.

Transcript Highlights:

• And then Senate File 205, regarding prioritization of chemotherapy medications, you know, we certainly
• Now, for this benefit, chemotherapy drugs can be pretty dangerous stuff, and so prior authorization in
• And then Senate File 205, regarding prioritization of chemotherapy medications, you know, we certainly
• Chair. you know chemotherapy drugs can be you know chemotherapy drugs can be pretty<00:12:12.480>
• met before deciding what chemotherapy drug you should have instead of your oncologist?

Keywords: 1187, senate, all